Annual CAPEX
$5.43 M
-$2.06 M-27.50%
31 December 2023
Summary:
Anika Therapeutics annual capital expenditures is currently $5.43 million, with the most recent change of -$2.06 million (-27.50%) on 31 December 2023. During the last 3 years, it has risen by +$3.80 million (+233.35%). ANIK annual CAPEX is now -66.60% below its all-time high of $16.25 million, reached on 31 December 2008.ANIK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$1.82 M
-$1.59 M-46.64%
30 September 2024
Summary:
Anika Therapeutics quarterly capital expenditures is currently $1.82 million, with the most recent change of -$1.59 million (-46.64%) on 30 September 2024. Over the past year, it has increased by +$1.07 million (+145.07%). ANIK quarterly CAPEX is now -78.69% below its all-time high of $8.52 million, reached on 31 December 2007.ANIK Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$8.87 M
+$1.07 M+13.80%
30 September 2024
Summary:
Anika Therapeutics TTM capital expenditures is currently $8.87 million, with the most recent change of +$1.07 million (+13.80%) on 30 September 2024. Over the past year, it has increased by +$2.75 million (+44.98%). ANIK TTM CAPEX is now -62.37% below its all-time high of $23.56 million, reached on 30 June 2008.ANIK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.5% | +145.1% | +45.0% |
| 3 y3 years | +233.3% | +41.4% | +98.6% |
| 5 y5 years | +16.6% | +324.3% | +225.8% |
ANIK CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -27.5% | +233.3% | -46.6% | +145.1% | at high | +98.6% |
| 5 y | 5 years | -27.5% | +233.3% | -46.6% | +881.6% | at high | +570.7% |
| alltime | all time | -66.6% | +5997.8% | -78.7% | -62.4% | +9862.9% |
Anika Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.82 M(-46.6%) | $8.87 M(+13.8%) |
| June 2024 | - | $3.40 M(+88.2%) | $7.79 M(+33.3%) |
| Mar 2024 | - | $1.81 M(-1.7%) | $5.85 M(+7.7%) |
| Dec 2023 | $5.43 M(-27.5%) | $1.84 M(+148.3%) | $5.43 M(-11.3%) |
| Sept 2023 | - | $741.00 K(-49.1%) | $6.12 M(-13.4%) |
| June 2023 | - | $1.46 M(+4.9%) | $7.07 M(-6.4%) |
| Mar 2023 | - | $1.39 M(-45.1%) | $7.55 M(+0.8%) |
| Dec 2022 | $7.49 M(+45.6%) | $2.53 M(+49.6%) | $7.49 M(+23.0%) |
| Sept 2022 | - | $1.69 M(-12.8%) | $6.08 M(+7.2%) |
| June 2022 | - | $1.94 M(+46.3%) | $5.68 M(-6.2%) |
| Mar 2022 | - | $1.33 M(+17.7%) | $6.05 M(+17.7%) |
| Dec 2021 | $5.14 M(+215.9%) | $1.13 M(-12.2%) | $5.14 M(+15.2%) |
| Sept 2021 | - | $1.28 M(-44.5%) | $4.46 M(+29.3%) |
| June 2021 | - | $2.31 M(+455.2%) | $3.45 M(+161.1%) |
| Mar 2021 | - | $417.00 K(-7.1%) | $1.32 M(-18.8%) |
| Dec 2020 | $1.63 M(-42.4%) | $449.00 K(+65.7%) | $1.63 M(+12.5%) |
| Sept 2020 | - | $271.00 K(+46.5%) | $1.45 M(-9.8%) |
| June 2020 | - | $185.00 K(-74.4%) | $1.60 M(-36.3%) |
| Mar 2020 | - | $723.00 K(+169.8%) | $2.52 M(-10.9%) |
| Dec 2019 | $2.83 M(-39.3%) | $268.00 K(-37.4%) | $2.83 M(+3.9%) |
| Sept 2019 | - | $428.00 K(-61.1%) | $2.72 M(-22.3%) |
| June 2019 | - | $1.10 M(+6.9%) | $3.50 M(+11.5%) |
| Mar 2019 | - | $1.03 M(+531.9%) | $3.14 M(-32.5%) |
| Dec 2018 | $4.66 M(-48.2%) | $163.00 K(-86.5%) | $4.66 M(-33.2%) |
| Sept 2018 | - | $1.21 M(+63.5%) | $6.97 M(-16.5%) |
| June 2018 | - | $740.00 K(-70.9%) | $8.35 M(-15.3%) |
| Mar 2018 | - | $2.54 M(+2.8%) | $9.85 M(+9.7%) |
| Dec 2017 | $8.98 M(-35.9%) | $2.47 M(-4.4%) | $8.98 M(+13.5%) |
| Sept 2017 | - | $2.59 M(+15.5%) | $7.91 M(-1.9%) |
| June 2017 | - | $2.24 M(+33.9%) | $8.06 M(-13.0%) |
| Mar 2017 | - | $1.68 M(+19.1%) | $9.27 M(-33.8%) |
| Dec 2016 | $14.01 M(+51.9%) | $1.41 M(-48.7%) | $14.01 M(-29.2%) |
| Sept 2016 | - | $2.74 M(-20.6%) | $19.80 M(+10.3%) |
| June 2016 | - | $3.45 M(-46.2%) | $17.96 M(+16.7%) |
| Mar 2016 | - | $6.42 M(-10.8%) | $15.39 M(+66.8%) |
| Dec 2015 | $9.22 M(+494.0%) | $7.20 M(+705.0%) | $9.22 M(+246.7%) |
| Sept 2015 | - | $894.00 K(+1.8%) | $2.66 M(+32.4%) |
| June 2015 | - | $878.00 K(+243.0%) | $2.01 M(+31.1%) |
| Mar 2015 | - | $256.00 K(-59.6%) | $1.53 M(-1.3%) |
| Dec 2014 | $1.55 M(+252.2%) | $632.90 K(+160.7%) | $1.55 M(+38.0%) |
| Sept 2014 | - | $242.80 K(-39.4%) | $1.13 M(+11.6%) |
| June 2014 | - | $400.80 K(+45.0%) | $1.01 M(+47.9%) |
| Mar 2014 | - | $276.50 K(+34.7%) | $681.70 K(+54.6%) |
| Dec 2013 | $441.00 K(-70.7%) | $205.20 K(+63.0%) | $441.00 K(-1.6%) |
| Sept 2013 | - | $125.90 K(+69.9%) | $448.00 K(-4.5%) |
| June 2013 | - | $74.10 K(+107.0%) | $469.10 K(-64.4%) |
| Mar 2013 | - | $35.80 K(-83.1%) | $1.32 M(-12.5%) |
| Dec 2012 | $1.50 M(+7.5%) | $212.20 K(+44.4%) | $1.50 M(-13.5%) |
| Sept 2012 | - | $147.00 K(-84.0%) | $1.74 M(-8.0%) |
| June 2012 | - | $921.40 K(+311.2%) | $1.89 M(+22.1%) |
| Mar 2012 | - | $224.10 K(-49.8%) | $1.55 M(+10.5%) |
| Dec 2011 | $1.40 M(-49.7%) | $446.40 K(+49.7%) | $1.40 M(-27.1%) |
| Sept 2011 | - | $298.20 K(-48.5%) | $1.92 M(-20.9%) |
| June 2011 | - | $579.20 K(+656.1%) | $2.43 M(+17.0%) |
| Mar 2011 | - | $76.60 K(-92.1%) | $2.08 M(-25.5%) |
| Dec 2010 | $2.79 M(-29.7%) | $967.30 K(+20.1%) | $2.79 M(+17.6%) |
| Sept 2010 | - | $805.40 K(+255.1%) | $2.37 M(-1.6%) |
| June 2010 | - | $226.80 K(-71.1%) | $2.41 M(-30.8%) |
| Mar 2010 | - | $785.50 K(+42.5%) | $3.48 M(-12.2%) |
| Dec 2009 | $3.96 M | $551.40 K(-34.7%) | $3.96 M(-17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | $845.00 K(-34.9%) | $4.78 M(-33.6%) |
| June 2009 | - | $1.30 M(+2.3%) | $7.21 M(-48.4%) |
| Mar 2009 | - | $1.27 M(-7.5%) | $13.96 M(-14.1%) |
| Dec 2008 | $16.25 M(+10.1%) | $1.37 M(-58.0%) | $16.25 M(-30.6%) |
| Sept 2008 | - | $3.27 M(-59.4%) | $23.40 M(-0.7%) |
| June 2008 | - | $8.05 M(+126.5%) | $23.56 M(+33.5%) |
| Mar 2008 | - | $3.56 M(-58.3%) | $17.65 M(+19.6%) |
| Dec 2007 | $14.76 M(+1030.0%) | $8.52 M(+148.2%) | $14.76 M(+131.4%) |
| Sept 2007 | - | $3.43 M(+60.4%) | $6.38 M(+107.5%) |
| June 2007 | - | $2.14 M(+224.8%) | $3.07 M(+92.2%) |
| Mar 2007 | - | $659.00 K(+361.5%) | $1.60 M(+22.4%) |
| Dec 2006 | $1.31 M(-18.4%) | $142.80 K(+9.0%) | $1.31 M(-22.2%) |
| Sept 2006 | - | $131.00 K(-80.3%) | $1.68 M(-27.2%) |
| June 2006 | - | $665.80 K(+81.8%) | $2.31 M(+21.3%) |
| Mar 2006 | - | $366.30 K(-29.0%) | $1.90 M(+18.8%) |
| Dec 2005 | $1.60 M(+237.9%) | $516.10 K(-32.0%) | $1.60 M(+40.6%) |
| Sept 2005 | - | $758.60 K(+191.0%) | $1.14 M(+99.1%) |
| June 2005 | - | $260.70 K(+299.2%) | $571.70 K(+46.6%) |
| Mar 2005 | - | $65.30 K(+21.6%) | $390.00 K(-17.7%) |
| Dec 2004 | $473.70 K(+85.0%) | $53.70 K(-72.0%) | $473.70 K(-7.1%) |
| Sept 2004 | - | $192.00 K(+143.0%) | $510.00 K(+45.3%) |
| June 2004 | - | $79.00 K(-47.0%) | $351.00 K(+13.6%) |
| Mar 2004 | - | $149.00 K(+65.6%) | $309.00 K(+20.7%) |
| Dec 2003 | $256.00 K(+187.6%) | $90.00 K(+172.7%) | $256.00 K(+42.2%) |
| Sept 2003 | - | $33.00 K(-10.8%) | $180.00 K(+0.1%) |
| June 2003 | - | $37.00 K(-61.5%) | $179.80 K(+5.7%) |
| Mar 2003 | - | $96.00 K(+585.7%) | $170.10 K(+91.1%) |
| Dec 2002 | $89.00 K(-90.2%) | $14.00 K(-57.3%) | $89.00 K(-24.8%) |
| Sept 2002 | - | $32.80 K(+20.1%) | $118.40 K(-63.5%) |
| June 2002 | - | $27.30 K(+83.2%) | $324.30 K(-58.9%) |
| Mar 2002 | - | $14.90 K(-65.7%) | $789.00 K(-13.2%) |
| Dec 2001 | $908.50 K(+79.8%) | $43.40 K(-81.8%) | $908.50 K(-5.0%) |
| Sept 2001 | - | $238.70 K(-51.5%) | $956.50 K(+27.3%) |
| June 2001 | - | $492.00 K(+266.1%) | $751.50 K(+36.9%) |
| Mar 2001 | - | $134.40 K(+47.0%) | $548.80 K(+8.6%) |
| Dec 2000 | $505.30 K(-71.0%) | $91.40 K(+171.2%) | $505.40 K(-33.0%) |
| Sept 2000 | - | $33.70 K(-88.4%) | $754.40 K(-42.9%) |
| June 2000 | - | $289.30 K(+217.9%) | $1.32 M(-7.7%) |
| Mar 2000 | - | $91.00 K(-73.3%) | $1.43 M(-17.8%) |
| Dec 1999 | $1.74 M(-20.9%) | $340.40 K(-43.3%) | $1.74 M(+8.8%) |
| Sept 1999 | - | $600.00 K(+50.0%) | $1.60 M(+14.3%) |
| June 1999 | - | $400.00 K(0.0%) | $1.40 M(-33.3%) |
| Mar 1999 | - | $400.00 K(+100.0%) | $2.10 M(-4.5%) |
| Dec 1998 | $2.20 M(+633.3%) | $200.00 K(-50.0%) | $2.20 M(+10.0%) |
| Sept 1998 | - | $400.00 K(-63.6%) | $2.00 M(+25.0%) |
| June 1998 | - | $1.10 M(+120.0%) | $1.60 M(+220.0%) |
| Mar 1998 | - | $500.00 K(+400.0%) | $500.00 K(+25.0%) |
| Dec 1997 | $300.00 K(-25.0%) | - | - |
| Aug 1996 | - | $100.00 K(>+9900.0%) | $400.00 K(-20.0%) |
| Aug 1996 | $400.00 K(+33.3%) | - | - |
| May 1996 | - | $0.00(-100.0%) | $500.00 K(-16.7%) |
| Feb 1996 | - | $100.00 K(-50.0%) | $600.00 K(+20.0%) |
| Nov 1995 | - | $200.00 K(0.0%) | $500.00 K(+66.7%) |
| Aug 1995 | $300.00 K(+50.0%) | $200.00 K(+100.0%) | $300.00 K(+50.0%) |
| May 1995 | - | $100.00 K(0.0%) | $200.00 K(0.0%) |
| Aug 1994 | $200.00 K(-85.7%) | $100.00 K(>+9900.0%) | $200.00 K(+100.0%) |
| May 1994 | - | $0.00(0.0%) | $100.00 K(0.0%) |
| Feb 1994 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| Nov 1993 | - | $100.00 K | $100.00 K |
| Aug 1993 | $1.40 M | - | - |
FAQ
- What is Anika Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Anika Therapeutics?
- What is Anika Therapeutics annual CAPEX year-on-year change?
- What is Anika Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Anika Therapeutics?
- What is Anika Therapeutics quarterly CAPEX year-on-year change?
- What is Anika Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Anika Therapeutics?
- What is Anika Therapeutics TTM CAPEX year-on-year change?
What is Anika Therapeutics annual capital expenditures?
The current annual CAPEX of ANIK is $5.43 M
What is the all time high annual CAPEX for Anika Therapeutics?
Anika Therapeutics all-time high annual capital expenditures is $16.25 M
What is Anika Therapeutics annual CAPEX year-on-year change?
Over the past year, ANIK annual capital expenditures has changed by -$2.06 M (-27.50%)
What is Anika Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of ANIK is $1.82 M
What is the all time high quarterly CAPEX for Anika Therapeutics?
Anika Therapeutics all-time high quarterly capital expenditures is $8.52 M
What is Anika Therapeutics quarterly CAPEX year-on-year change?
Over the past year, ANIK quarterly capital expenditures has changed by +$1.07 M (+145.07%)
What is Anika Therapeutics TTM capital expenditures?
The current TTM CAPEX of ANIK is $8.87 M
What is the all time high TTM CAPEX for Anika Therapeutics?
Anika Therapeutics all-time high TTM capital expenditures is $23.56 M
What is Anika Therapeutics TTM CAPEX year-on-year change?
Over the past year, ANIK TTM capital expenditures has changed by +$2.75 M (+44.98%)